Heart disease is the main cause of death in developed countries. There is evidence that shows that factors related to lifestyle, such as diet, have an influence on developing these kinds of diseases. But, do they have any ...
Dec 4, 2020
0
6
Glucocorticoids are steroids widely prescribed to treat a range of immune-mediated inflammatory diseases. While high doses of steroids are known to increase the risk of cardiovascular disease, the impact of lower doses is ...
Dec 3, 2020
0
18
Pregnancy-related heart attacks—especially in the period after childbirth—are on the rise in women who are 30 or older, according to new research.
Oct 27, 2020
0
2
The OPTIMIZE randomized trial comparing a novel, low-profile drug-eluting stent (DES) facilitating transradial access (TR) and direct stenting (DS) to existing DES did not establish non-inferiority of the new stent based ...
Oct 19, 2020
0
0
New data from PROSPECT ABSORB, a pilot randomized trial of percutaneous coronary intervention (PCI) of non-flow-limiting vulnerable plaques in native coronary arteries, found that PCI was safe, substantially enlarged follow-up ...
Oct 15, 2020
0
1
Seasonal influenza vaccine development and mass production, as well as three international influenza vaccine cardiovascular outcomes trials currently underway, may inform future efforts targeted at developing and evaluating ...
Oct 5, 2020
0
3
The calcification of the carotid artery is a sign of advanced arteriosclerosis, which may be associated with chronic coronary artery disease (CAD) and can lead to death. Such calcification can be seen in regular oral panoramic ...
Sep 16, 2020
0
3
Restricting blood transfusion in anemic heart attack patients to those with very low hemoglobin levels saves blood with no negative impact on clinical outcomes. That's the finding of the REALITY trial presented in a Hot Line ...
Sep 2, 2020
0
2
(HealthDay)—During the early COVID-19 period, there was a decrease in hospitalization rates for acute myocardial infarction (AMI), according to a brief report published online Aug. 7 in JAMA Cardiology.
Aug 10, 2020
0
1
(HealthDay)—For elderly or low-weight patients with acute coronary syndrome (ACS), a reduced dose of prasugrel is efficacious compared with ticagrelor, according to a study published online July 21 in the Annals of Internal ...
Jul 21, 2020
0
2
